Media

Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market

Adcendo ApS Announces First Patient Dosed in Phase I/II ADCElerate1 Trial of ADCE-D01

New Financing and Board Members for Positrigo

Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Bleeding Disorder Programs at the ISTH 2025 Congress

Kivu Bioscience Selects Sterling Pharma Solutions for cGMP Manufacturing of Lead Oncology Antibody-Drug Conjugate KIVU-107

HealthCap V distributes its holding in BONESUPPORT to its limited partners and general partner

HealthCap V distributes its holding in BONESUPPORT to its limited partners and general partner

Vicore Presents New Data at the 2025 American Thoracic Society International Conference

Oncopeptides launches new real-world evidence study of Pepaxti in Spain, first patient enrolled

Oncopeptides publishes Q1 report 2025